parthenolide and Pituitary Neoplasms

parthenolide has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asaba, K; Hashimoto, K; Iwasaki, Y; Nishiyama, M; Taguchi, T; Takao, T1

Other Studies

1 other study(ies) available for parthenolide and Pituitary Neoplasms

ArticleYear
Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo.
    The Journal of endocrinology, 2006, Volume: 188, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Corticosterone; Dehydroepiandrosterone; Estradiol; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; NF-kappa B; Pituitary Neoplasms; Pro-Opiomelanocortin; Repressor Proteins; RNA, Messenger; RNA, Neoplasm; Sesquiterpenes; Survivin; Testosterone; Transcription, Genetic; Tumor Cells, Cultured

2006